Skip to main content
Journal of Refractive Surgery, 2019;35(9):591–598
Published Online:https://doi.org/10.3928/1081597X-20190815-01Cited by:5

Abstract

PURPOSE:

To analyze the efficacy, safety, predictability, and stability in hyperopic presbyopic laser in situ keratomileusis (LASIK) surgeries with the TENEO 317 algorithm (Bausch & Lomb Technolas, Munich, Germany).

METHODS:

Eighty eyes from 40 patients who underwent hyperopic and presbyopic LASIK in this retrospective, observational, and longitudinal study were included. All patients had a 24-month follow-up. Excimer laser treatment was performed with TECNOLAS Perfect Vision GmbH TENEO 317 software version 1.25 (Bausch & Lomb) with the PROSCAN platform for the distance dominant eye and the SUPRACOR mild platform for the near dominant eye.

RESULTS:

Mean age was 53.90 ± 4.84 years (range: 42 to 66 years). Postoperative uncorrected distance visual acuity (UDVA) was 0.00 ± 0.04 (20/19.97) for the dominant eye and 0.14 ± 0.05 (20/27.65) for the non-dominant eye. Postoperative uncorrected near visual acuity was 0.51 ± 0.17 (J9) for the dominant eye and 0.09 ± 0.06 (J1.5) for the non-dominant eye, whereas 2.5% of non-dominant eyes lost two lines of corrected distance visual acuity. Half of non-dominant eyes lost one line, and 2.5% of dominant and non-dominant eyes changed 0.50 D or more between 3 and 24 months.

CONCLUSIONS:

PROSCAN surgery in the dominant eye and SUPRACOR surgery in the non-dominant eye using the TENEO 317 algorithm demonstrated that the hyperopic presbyopic excimer laser surgery technique resulted in acceptable and stable outcomes after 24 months of follow-up.

[J Refract Surg. 2019;35(9):591–598.]

  • 1.Chang JSM, Ng JCM, Lau SYF. Visual outcomes and patient satisfaction after presbyopic lens exchange with a diffractive multifocal intraocular lens. J Refract Surg. 2012; 28:468–475.10.3928/1081597X-20120612-01

    LinkGoogle Scholar
  • 2.Bouzoukis DI, Kymionis GD, Panagopoulou SI, et al.Visual outcomes and safety of a small diameter intrastromal refractive inlay for the corneal compensation of presbyopia. J Refract Surg. 2012; 28:168–173.10.3928/1081597X-20120124-02

    LinkGoogle Scholar
  • 3.Stahl JE. Conductive keratoplasty for presbyopia: 3-year results. J Refract Surg. 2007; 23:905–910.10.3928/1081-597X-20071101-07

    LinkGoogle Scholar
  • 4.Wirbelauer C, Karandish A, Aurich H, Pham DT. Imaging scleral expansion bands for presbyopia with optical coherence tomography. J Cataract Refract Surg. 2003; 29:2435–2438.10.1016/j.jcrs.2003.02.001

    Crossref MedlineGoogle Scholar
  • 5.Schallhorn SC, Teenan D, Venter JA, et al.Monovision LASIK versus presbyopia-correcting IOLs: comparison of clinical and patient-reported outcomes. J Refract Surg. 2017; 33:749–758.10.3928/1081597X-20170721-03

    LinkGoogle Scholar
  • 6.Reinstein DZ, Carp GI, Archer TJ, Gobbe M. LASIK for presbyopia correction in emmetropic patients using aspheric ablation profiles and a micro-monovision protocol with the Carl Zeiss Meditec MEL 80 and VisuMax. J Refract Surg. 2012; 28:531–539.10.3928/1081597X-20120723-01

    LinkGoogle Scholar
  • 7.Wolffsohn JS, Davies LN. Presbyopia: effectiveness of correction strategies. Prog Retin Eye Res. 2019; 68:124–143.10.1016/j.preteyeres.2018.09.004

    Crossref MedlineGoogle Scholar
  • 8.Renna A, Alió JL, Vejarano LF. Pharmacological treatments of presbyopia: a review of modern perspectives. Eye Vis. 2017; 4:3.10.1186/s40662-017-0068-8

    Crossref MedlineGoogle Scholar
  • 9.Thomas BC, Fitting A, Auffarth GU, Holzer MP. Femtosecond laser correction of presbyopia (INTRACOR) in emmetropes using a modified pattern. J Refract Surg. 2012; 28:872–878.10.3928/1081597X-20121115-03

    LinkGoogle Scholar
  • 10.Saib N, Abrieu-Lacaille M, Berguiga M, Rambaud C, Froussart-Maille F, Rigal-Sastourne J-C. Central PresbyLASIK for hyperopia and presbyopia using micro-monovision with the Technolas 217P platform and SUPRACOR algorithm. J Refract Surg. 2015; 31:540–546.10.3928/1081597X-20150727-04

    LinkGoogle Scholar
  • 11.Ruiz LA, Cepeda LM, Fuentes VC. Intrastromal correction of presbyopia using a femtosecond laser system. J Refract Surg. 2009; 25:847–854.10.3928/1081597X-20090917-05

    LinkGoogle Scholar
  • 12.Ruiz LA, inventor. Apparatus and method for performing presbyopia corrective surgery. US patent 5 533 997, 1996.

    Google Scholar
  • 13.Cantú R, Rosales MA, Tepichín E, Curioca A, Montes V, Bonilla J. Advanced surface ablation for presbyopia using the Nidek EC-5000 laser. J Refract Surg. 2004; 20(5 suppl):S711–S713.15521273

    AbstractGoogle Scholar
  • 14.Telandro A. Pseudo-accommodative cornea: a new concept for correction of presbyopia. J Refract Surg. 2004; 20(5 suppl):S714–S717.15521274

    AbstractGoogle Scholar
  • 15.Jackson WB, Tuan KA, Mintsioulis G. Aspheric wavefront-guided LASIK to treat hyperopic presbyopia: 12-month results with the VISX platform. J Refract Surg. 2011; 27:519–529.10.3928/1081597X-20101110-02

    LinkGoogle Scholar
  • 16.Gordon M. Presbyopia corrections with the WaveLight ALLEGRETTO: 3-month results. J Refract Surg. 2010; 26:S824–S826.10.3928/1081597X-20100921-10

    LinkGoogle Scholar
  • 17.Uthoff D, Pölzl M, Hepper D, Holland D. A new method of cornea modulation with excimer laser for simultaneous correction of presbyopia and ametropia. Graefes Arch Clin Exp Ophthalmol. 2012; 250:1649–1661.10.1007/s00417-012-1948-1

    Crossref MedlineGoogle Scholar
  • 18.Ryan A, O'Keefe M. Corneal approach to hyperopic presbyopia treatment: six-month outcomes of a new multifocal excimer laser in situ keratomileusis procedure. J Cataract Refract Surg. 2013; 39:1226–1233.10.1016/j.jcrs.2013.03.016

    Crossref MedlineGoogle Scholar
  • 19.Alarcón A, Anera RG, Soler M, del Barco LJ. Visual evaluation of different multifocal corneal models for the correction of presbyopia by laser ablation. J Refract Surg. 2011; 27:833–836.10.3928/1081597X-20111005-02

    LinkGoogle Scholar
  • 20.Pinelli R, Ortiz D, Simonetto A, Bacchi C, Sala E, Alió JL. Correction of presbyopia in hyperopia with a center-distance, paracentral-near technique using the Technolas 217z platform. J Refract Surg. 2008; 24:494–500.10.3928/1081597X-20080501-07

    LinkGoogle Scholar
  • 21.Schlote T, Heuberger A. Multifocal corneal ablation (Supracor) in hyperopic presbyopia: 1-year results in a cross-sectional study. Eur J Ophthalmol. 2017; 27:438–442.10.5301/ejo.5000871

    Crossref MedlineGoogle Scholar
  • 22.Ang RET, Cruz EM, Pisig AU, Solis MLPC, Reyes RMM, Youssefi G. Safety and effectiveness of the SUPRACOR presbyopic LASIK algorithm on hyperopic patients. Eye Vis. 2016; 3:33.10.1186/s40662-016-0062-6

    Crossref MedlineGoogle Scholar
  • 23.Seijas O, Gómez de Liaño P, Gómez de Liaño R, Roberts CJ, Piedrahita E, Diaz E. Ocular dominance diagnosis and its influence in monovision. Am J Ophthalmol. 2007; 144:209–216.10.1016/j.ajo.2007.03.053

    Crossref MedlineGoogle Scholar
  • 24.Abrieu-Lacaille M, Saib N, Rambaud C, et al.Management of presbyopic hyperopes by centered presbyLASIK [article in French]. J Fr Ophtalmol. 2014; 37:682–688.10.1016/j.jfo.2014.02.011

    Crossref MedlineGoogle Scholar
  • 25.Soler Tomás JR, Fuentes-Páez G, Burillo S. Symmetrical versus asymmetrical PresbyLASIK: results after 18 months, and patient satisfaction. Cornea. 2015; 34:651–657.10.1097/ICO.0000000000000339

    Crossref MedlineGoogle Scholar
  • 26.Cosar CB, Sener AB. Supracor hyperopia and presbyopia correction: 6-month results. Eur J Ophthalmol. 2014; 24:325–329.10.5301/ejo.5000371

    Crossref MedlineGoogle Scholar
  • 27.Stival LR, Figueiredo MN, Santhiago MR. Presbyopic excimer laser ablation: a review. J Refract Surg. 2018; 34:698–710.10.3928/1081597X-20180726-02

    LinkGoogle Scholar
  • 28.El Danasoury AM, Gamaly TO, Hantera M. Multizone LASIK with peripheral near zone for correction of presbyopia in myopic and hyperopic eyes: 1-year results. J Refract Surg. 2009; 25:296–305.19370826

    LinkGoogle Scholar
  • 29.Moshirfar M, D Desautels J, D Walker B, S Murri M, C Birdsong O, C Hoopes P. Mechanisms of optical regression following corneal laser refractive surgery: epithelial and stromal responses. Med Hypothesis Discov Innov Ophthalmol J. 2018; 7:1–9.

    MedlineGoogle Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×